Grifols (GIKLY) Capital Leases (2015 - 2018)

Grifols (GIKLY) posted Capital Leases of $10.9 million for Q4 2018, up 70.73% quarter-over-quarter from $6.4 million in Q4 2017, and up 70.73% year-on-year from $6.4 million in Q4 2017.

Grifols (GIKLY) Capital Leases (2015 - 2018) Analysis & Trends

Grifols (GIKLY) has reported Capital Leases for 4 consecutive years, with $10.9 million the latest figure, recorded in Q4 2018.

  • Capital Leases for Q4 2018 came in at $10.9 million, up 70.73% year-over-year; the trailing twelve-month figure through Dec 2018 was $10.9 million (up 70.73% YoY), and the FY2018 annual result was $10.9 million, up 70.73% from the prior year.
  • Capital Leases was $10.9 million for Q4 2018 at Grifols, up from $6.4 million in the prior quarter.
  • Over five years, Capital Leases peaked at $10.9 million in Q4 2018 and troughed at $6.4 million in Q4 2017.
  • Average Capital Leases over 4 years is $7.4 million, with a median of $6.6 million recorded in 2016.
  • Year-over-year, Capital Leases declined 2.97% in 2017 and surged 70.73% in 2018.
  • Over 4 years, Capital Leases stood at $6.4 million in 2015, then advanced by 2.44% to $6.6 million in 2016, then fell by 2.97% to $6.4 million in 2017, then jumped by 70.73% to $10.9 million in 2018.
  • Per Business Quant data, the three most recent Capital Leases figures were $10.9 million in Q4 2018, $6.4 million in Q4 2017, and $6.6 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2018 10.89 Mn
Dec 31, 2017 6.38 Mn
Dec 31, 2016 6.57 Mn
Mar 31, 2016 6.90 Mn
Dec 31, 2015 6.41 Mn